financetom
Business
financetom
/
Business
/
Aegon Names Will Fuller as Chief Operating Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aegon Names Will Fuller as Chief Operating Officer
Jun 17, 2026 1:43 AM

04:15 AM EDT, 06/17/2026 (MT Newswires) -- Aegon ( AEG ) has appointed Will Fuller as chief operating officer, effective Jan. 1, 2027, the company said Wednesday.

Fuller currently serves as chief executive of Aegon's ( AEG ) Transamerica operations.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Knot Offshore Partners Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing
Knot Offshore Partners Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing
Jun 17, 2026
04:11 AM EDT, 06/17/2026 (MT Newswires) -- Trygve Seglem, Director, on June 15, 2026, executed a purchase for 1,250,000 shares in Knot Offshore Partners ( KNOP ) for $25,000,000. Following the Form 4 filing with the SEC, Seglem has control over a total of 11,462,361 shares of the company, with 1,458,333 Series A preferred units, 9,661,255 common units, 90,368 common...
Aegon Names Will Fuller as Chief Operating Officer
Aegon Names Will Fuller as Chief Operating Officer
Jun 17, 2026
04:15 AM EDT, 06/17/2026 (MT Newswires) -- Aegon ( AEG ) has appointed Will Fuller as chief operating officer, effective Jan. 1, 2027, the company said Wednesday. Fuller currently serves as chief executive of Aegon's ( AEG ) Transamerica operations. ...
Form 8.3
Form 8.3
Jun 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: River Global Investors LLP - 213800HIGHFCAY9K8Z97 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Vedana Therapeutics launches with $46 million to develop migraine treatments
Vedana Therapeutics launches with $46 million to develop migraine treatments
Jun 17, 2026
June 17 (Reuters) - Vedana Therapeutics emerged from stealth on Wednesday with $46 million in funding, which will be used to develop next-generation therapies for migraine prevention. Here are the details: * The Series A financing round was co-led by Westlake BioPartners and Canaan Partners, with participation from Dawn Biopharma and Alexandria Venture Investments. * Migraine, which affects more than...
Copyright 2023-2026 - www.financetom.com All Rights Reserved